Girard Sharp LLP is investigating potential claims on behalf of Livent stockholders who received shares of Arcadium Lithium (NYSE: ALTM) through the 2024 merger.
If you are a former Livent stockholder who received Arcadium stock in the 2024 merger, please fill out our form or call (866) 981-4800 for a free consultation.
Arcadium Lithium (NYSE: ALTM) Stock Plummets Over $4.8 Bn.
On January 4, 2024, Livent, a lithium chemical production company, merged with Allkem to create Arcadium, the world’s fifth-largest lithium producer. After the merger’s completion, Hunterbrook Media’s investigation revealed the potentially greater-than-expected environmental impact of Arcadium’s production operations and undisclosed environmental litigation against the company in Argentina. Since Arcadium entered the New York Stock Exchange, the company has lost 45% of its market cap or $4.8 billion.
Receive Arcadium stock through the 2024 merger as a former Livent stockholder? Speak to a Girard Sharp attorney about your rights.
Our Commitment to Excellence
Girard Sharp represents investors, consumers, and institutions in class actions and other complex litigation nationwide. We serve on the Plaintiffs’ executive committee in the recent spoofing litigation against JPMorgan Chase that settled for $60 million, a favorable resolution that the district court preliminarily approved in December 2021. Our attorneys have obtained multimillion-dollar recoveries for victims of unfair and deceptive practices in antitrust, financial fraud, and consumer protection matters against some of the country’s largest corporations, including Raymond James, John Hancock, and Sears. Girard Sharp has earned top-tier rankings from U.S. News and World Report for Securities and Class Action Litigation and has been repeatedly selected as an Elite Trial Lawyers finalist by the National Law Journal.
